ANI Pharmaceuticals ANIP Cash Flow Statement
| Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | ||
|---|---|---|---|---|---|---|
| $29.49M+7.3% | $27.49M+3.3% | $26.62M+211% | $8.55M-45.5% | $15.68M+253% | ||
| $20.92M-7.5% | $22.61M-0.1% | $22.63M-2.8% | $23.28M+1.7% | $22.89M+1.3% | ||
| $10.19M+4.3% | $9.77M+0.8% | $9.69M+0.9% | $9.6M+8.3% | $8.87M+25.6% | ||
| $58.38M+92.2% | $30.37M-31.1% | $44.06M-41.9% | $75.81M+117% | $34.99M+121% | ||
| $6.07M+388% | $1.24M-79.6% | $6.1M+52.0% | $4.01M+62.2% | $2.47M+3.3% | ||
| -$11.32M-707% | -$1.4M+77.2% | -$6.16M+10.8% | -$6.91M+65.2% | -$19.85M-85.8% | ||
| $0— | $0-100% | $344K-15.5% | $407K+0.2% | $406K0.0% | ||
| $19.76M+3,133% | $611K-41.5% | $1.04M+89.5% | $551K-94.5% | $10M+3,046% | ||
| $4.06M+167% | -$6.09M-400% | $2.03M0.0% | $2.03M0.0% | $2.03M-99.3% | ||
| -$21.62M-366% | -$4.64M— | —— | -$1.75M+82.4% | -$9.91M— | ||
| $25.59M+11.4% | $22.98M-48.7% | $44.81M-34.1% | $68M+1,276% | $4.94M+4,118% | ||
| $52.3M+79.6% | $29.12M-23.3% | $37.95M-47.1% | $71.8M+121% | $32.52M+141% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- How much cash does ANI Pharmaceuticals generate?
- ANI Pharmaceuticals (ANIP) generated $208.6M in operating cash flow over the trailing twelve months.
- What is ANI Pharmaceuticals's free cash flow?
- After $17.4M of capital expenditures, ANI Pharmaceuticals's free cash flow was $191.2M over the trailing twelve months, up 187.0% year over year.
- Where does ANI Pharmaceuticals's cash flow data come from?
- Every line is extracted from ANI Pharmaceuticals's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.
